CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia
- 21 April 2005
- journal article
- Published by Springer Nature in Leukemia
- Vol. 19 (7) , 1281-1284
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono‐ and bi‐allelic 9p21 deletions in childhood acute lymphoblastic leukemiaGenes, Chromosomes and Cancer, 2003
- Deletion analysis of p16INKa and p15INKb in relapsed childhood acute lymphoblastic leukemiaBlood, 2002
- INK4A/ARF deletions are acquired at relapse in childhood acute lymphoblastic leukaemia: a paired study on 25 patients using real-time polymerase chain reactionBritish Journal of Haematology, 2001
- Different patterns of homozygous p16INK4A and p15INK4B deletions in childhood acute lymphoblastic leukemias containing distinct E2A translocationsLeukemia, 1998
- Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia–lymphoma cellsLeukemia, 1998
- Prognostic importance of p15INK4B and p16INK4 gene inactivation in childhood acute lymphocytic leukemia.Journal of Clinical Oncology, 1996
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994